EARNEST PARTNERS LLC - Mast Therapeutics Inc ownership

Back to all holdings Add to watchlist

Mast Therapeutics Inc's ticker is and the CUSIP is MSTX. A total of 1 filers reported holding Mast Therapeutics Inc in Q2 2013. The put-call ratio across all filers is - and the average weighting 0.0%.

Links
Filings
Quarter-by-quarter ownership
EARNEST PARTNERS LLC ownership history of Mast Therapeutics Inc
ValueSharesWeighting
Q3 2013$3,0000.0%7,8000.0%0.00%–
Q2 2013$3,000–7,800–0.00%–
 Download
Other shareholders
Mast Therapeutics Inc shareholders Q2 2013
NameSharesValueWeighting ↓
EARNEST PARTNERS LLC 7,800$3,0000.00%
View complete list of Mast Therapeutics Inc shareholders